Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)

Phillip A. Angart, Rebecca J. Carlson, Sarah Thorwall, S. Patrick Walton

Research output: Contribution to journalArticle

Abstract

Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.

LanguageEnglish (US)
Pages1-8
Number of pages8
JournalApplied Microbiology and Biotechnology
DOIs
StateAccepted/In press - May 2 2017

Profile

Brevibacillus
Brain-Derived Neurotrophic Factor
Cystine
Nerve Growth Factors
Nervous System Diseases
Spinal Cord Injuries

Keywords

  • BDNF
  • Bioactive
  • Brain-derived neurotrophic factor
  • Brevibacillus choshinensis
  • Cystine-knot protein
  • Neurotrophin
  • Recombinant

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology

Cite this

Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF). / Angart, Phillip A.; Carlson, Rebecca J.; Thorwall, Sarah; Patrick Walton, S.

In: Applied Microbiology and Biotechnology, 02.05.2017, p. 1-8.

Research output: Contribution to journalArticle

@article{c1b1a0aba6664120999772e3dfb78116,
title = "Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)",
abstract = "Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.",
keywords = "BDNF, Bioactive, Brain-derived neurotrophic factor, Brevibacillus choshinensis, Cystine-knot protein, Neurotrophin, Recombinant",
author = "Angart, {Phillip A.} and Carlson, {Rebecca J.} and Sarah Thorwall and {Patrick Walton}, S.",
year = "2017",
month = "5",
day = "2",
doi = "10.1007/s00253-017-8273-x",
language = "English (US)",
pages = "1--8",
journal = "Applied Microbiology and Biotechnology",
issn = "0175-7598",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Use of Brevibacillus choshinensis for the production of biologically active brain-derived neurotrophic factor (BDNF)

AU - Angart,Phillip A.

AU - Carlson,Rebecca J.

AU - Thorwall,Sarah

AU - Patrick Walton,S.

PY - 2017/5/2

Y1 - 2017/5/2

N2 - Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.

AB - Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family critical for neuronal cell survival and differentiation, with therapeutic potential for the treatment of neurological disorders and spinal cord injuries. The production of recombinant, bioactive BDNF is not practical in most traditional microbial expression systems because of the inability of the host to correctly form the characteristic cystine-knot fold of BDNF. Here, we investigated Brevibacillus choshinensis as a suitable expression host for bioactive BDNF expression, evaluating the effects of medium type (2SY and TM), temperature (25 and 30 °C), and culture time (48–120 h). Maximal BDNF bioactivity (per unit mass) was observed in cultures grown in 2SY medium at extended times (96 h at 30 °C or >72 h at 25 °C), with resulting bioactivity comparable to that of a commercially available BDNF. For cultures grown in 2SY medium at 25 °C for 72 h, the condition that led to the greatest quantity of biologically active protein in the shortest culture time, we recovered 264 μg/L of BDNF. As with other microbial expression systems, BDNF aggregates did form in all culture conditions, indicating that while we were able to recover biologically active BDNF, further optimization of the expression system could yield still greater quantities of bioactive protein. This study provides confirmation that B. choshinensis is capable of producing biologically active BDNF and that further optimization of culture conditions could prove valuable in increasing BDNF yields.

KW - BDNF

KW - Bioactive

KW - Brain-derived neurotrophic factor

KW - Brevibacillus choshinensis

KW - Cystine-knot protein

KW - Neurotrophin

KW - Recombinant

UR - http://www.scopus.com/inward/record.url?scp=85018372362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018372362&partnerID=8YFLogxK

U2 - 10.1007/s00253-017-8273-x

DO - 10.1007/s00253-017-8273-x

M3 - Article

SP - 1

EP - 8

JO - Applied Microbiology and Biotechnology

T2 - Applied Microbiology and Biotechnology

JF - Applied Microbiology and Biotechnology

SN - 0175-7598

ER -